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Objective: Although scaffold composition and architecture are considered to be important parameters for
tissue engineering, their inﬂuence on gene expression and cell differentiation is rarely investigated in
scaffolds used for matrix-associated autologous chondrocyte transplantation (MACT). In this study we
have therefore comparatively analyzed the gene expression of important chondrogenic markers in four
clinical applied cell-graft systems with very different scaffold characteristics.
Methods: Residuals (n¼ 165) of four different transplant types (MACI, HyalograftC, CaReS and
Novocart3D) were collected during surgery and analyzed for Col1, Col2, aggrecan, versican, melanoma
inhibitory activity (MIA) and IL-1b by real-time PCR. Scaffold and cell morphology were evaluated by
histology and electron microscopy.
Results: Despite the cultivation on 3D scaffolds, the cell differentiation on all transplant types didn’t reach
the levels of native cartilage. Gene expression highly differed between the transplant types. The highest
differentiation of cells (Col2/Col1 ratio) was found in CaReS, followed by Novocart3D, HyalograftC
and MACI. IL-1b expression also exhibited high differences between the scaffolds showing low
expression levels in Novocart3D and CaReS and higher expression levels in MACI and HyalograftC.
Conclusions: Our data indicate that scaffold characteristics as well as culture conditions highly inﬂuence
gene expression in cartilage transplants and that these parameters may have profound impact on the
tissue regeneration after MACT.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Lesions of articular cartilage are a large medical-therapeutic
problem, as self regeneration potential of cartilage is very limited.
Untreated cartilage defects often lead to ongoing pain, negatively
affects quality of life and predispose for osteoarthritis in the long
term1e3. Therefore articular cartilage injuries are a prime target for
regenerative techniques such as tissue engineering.
In contrast with other surgical techniques, which often lead to
the formation of ﬁbrous or ﬁbrocartilaginous tissue4, tissue engi-
neering aims to restore the complex structure and properties of
native cartilage by the chondrogenic potential of transplanted cells5.
Chondrocytes, which are responsible for the production and
homeostasis of cartilage extracellular matrix (ECM), areto: C. Albrecht, Medical
ogy, Center for Joint and
stria. Tel: 43-1-40400-5964;
.at (C. Albrecht).
s Research Society International. Pencapsulated by their own matrix and are not available for healing
of cartilage defects under natural conditions. To overcome this
problem for tissue engineering, chondrocytes are isolated from
small biopsies of cartilage taken from a non-weight-bearing area of
the joint, propagated in vitro, and implanted into the cartilage
defect. During proliferation in monolayer culture, however, the
chondrocytes become ﬁbroblast-like and cease the production of
Col2, aggrecan and others that account for the speciﬁc mechanical
properties of cartilage in vivo6e8. In order to obtain a tissue similar to
native cartilage this dedifferentiation process has to be reversed.
The most commonway to induce redifferentiation is to relocate the
cells into a 3D environment. This is reached by seeding the cells on
different graft systems9,10. Othermethods, including the application
of low oxygen tension11,12, mechanical stimulation13,14 or the addi-
tion of differentiation factors15,16, are also described in literature.
The success of grafts lies in mimicking native structure and in
support of cell growth and production of tissue-speciﬁc ECM. In the
case of a surgical procedure the use of grafts also facilitates the
handling and implantation of the cells. The newest generation of the
autologous chondrocyte transplantation takes advantages of theseublished by Elsevier Ltd. All rights reserved.
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drocyte transplantation (MACT)17. To meet the requirements for the
clinical use, a scaffold must be highly bio-compatible, non-toxic,
resorbable andhas to fulﬁl speciﬁcmechanical propertiese including
stability and resilience. A lot of research has been done to develop
new biomaterials that can serve as scaffolds and promote chondro-
genic differentiation. However, despite the huge variety of available
scaffolds, only few of them are in clinical use today. These scaffolds
differ highly in their manufacturing process, composition and
mechanical properties, and can be classiﬁed in natural biomaterials,
which are further distinguished as protein-based (collagen,
ﬁbrin18,19) andpolysaccharide-based biomaterials (alginate, chitosan,
hyaluronic acid, cellulose20e23), and in synthetic biomaterials (poly
[lactic-co-glycolic acid] (PGA), polyethylene glycol (PEG)24e26).
Recently, new promising techniques to optimize the adhesion,
growth and differentiation of the cells have come into the focus of
interest including surface modiﬁcations27,28, coating with bioactive
molecules29 and designed materials30,31.
However, the inﬂuence of scaffold characteristics on the gene
expression and differentiation of chondrocytes in clinical applied
materials remain poorly investigated. In particular, comparative
studies including more than two of those scaffolds are missing. We
recently have demonstrated that certain scaffold parameters could
inﬂuence cell distribution and adhesion32. In this study we have
focused on the differences in gene expression and differentiation of
the cells in four clinical applied scaffolds that exhibit a highly
different composition andmorphology21,33e35. For this purpose 165
transplant samples aswell as 26 biopsieswere assessed by real-time
PCR in terms of their matrix production (Col2, Col1, aggrecan, ver-
sican), expression of the differentiation factor melanoma inhibitory
activity (MIA) and the proinﬂammatory parameter IL-1b.
Materials and methods
Cartilage and transplant specimens
Residuals of four different types of MACT grafts (n¼ 165 trans-
plants in 165 patients) were used: HyalograftC autografts (Fidia
Advanced Biomaterials, Italy), a hyaluronanweb; MACI (Genzyme,
USA, former Verigen, Germany) a collagen type I/III membrane. This
collagenmembrane is manufactured by Geistlich (Switzerland) and
is separately available under the trade name Chondro-Gide.
Genzyme (former Verigen, which was bought by Genzyme in 2005)
uses this membrane to produce their chondrocyte transplant called
MACI in a production facility in Europe. The collagen type I gel
CaReS (Arthro Kinetics Biotechnology GmbH; Austria); and
Novocart3D (TeTeC, Germany), which is a bilayered collagen type I
sponge containing chondroitin-sulphate.
The grafts are produced by the companies as follows:
HyalograftC autograft: The patient’s chondrocytes are isolated
from biopsies and multiplied in a monolayer culture. According to
the company the maximum number of passages for 2D cultivation
is deﬁned in the production process, which was not further speci-
ﬁed. The cells are thereafter seeded onto the surface of the
HyalograftC web at a density of 1106/cm2 and cultivated for at
least 2 weeks. The cells are cultivated in foetal calf serum.
MACI: After isolation of chondrocytes from biopsies, the cells
are propagated in monolayer and seeded on the rough side of the
ﬂeece. Cell number and cultivation time are not exactly given, but
according to personal communication, the maximum number of
passages is set below the critical number deﬁned by their own data,
which was not further speciﬁed. 3D cultivation time is about
1 week. The cells are cultivated in autologous serum.
CaReS: As opposed to the three other graft types investigated
in this study, the patient’s chondrocytes are mixed with the geldirectly after isolation from the biopsies without monolayer culti-
vation. 3D cultivation is performed for 2 weeks (10e14 days). The
cells are cultivated in autologous serum.
Novocart 3D: Patient’s chondrocytes are isolated from full
depth cartilage cylinders, multiplied in monolayer without getting
passaged and seeded in a density of 1.45106/cm2 onto the scaf-
fold. Those constructs are cultivated for about 2 days under 3D
conditions before sending the graft to the hospital. The cells are
cultivated in homologous serum.
The required amount of cartilage tissue was obtained from biop-
sies from the femoral intercondylar notch of the knee during
arthroscopyand sent to the companies for further processing. A small
sample of some biopsies (n¼ 26) was kept in the hospital for further
analysis. Per patientonlyonebiopsywas taken from theaffectedknee
joint and used for analysis. Samples of the cartilage transplants were
collected during surgery and stored in the transportmedium at room
temperature. Immediately after surgery the samples were brought to
the lab for further processing. The surgerieswere all done in the same
hospital by one surgeon. Clinical studies were approved by the local
ethical board and patient consent was given (147/2003, 148/2003,
420/2003, 307/2006, 738/2010).
RNA extraction and puriﬁcation
Lysis of the cells was performed by adding 1 ml of TRI Reagent
(SigmaeAldrich) to the MACI, HyalograftC and Novocart 3D
scaffold. RNA isolation was performed according to the standard
protocol.
For total RNA extraction from native cartilage and the CaReS
gel, the samples were frozen in liquid nitrogen and ground using
a mortar and pestle. Further steps were performed using the
RNeasy plant mini kit (Quiagen, Germany). The procedure for
isolating total RNA was executed as described in the RNeasyMini
Handbook (Qiagen, Germany, 06/2001).
cDNA synthesis
Total RNA (0.1e1 mg) was diluted with nuclease-free water to
a volume of 15 ml. Thereafter 4 ml iScript Reaction Mix, as well as
1 ml iScript Reverse Transkriptase were added (Bio-Rad Labora-
tories, California, USA). The reaction mixture was incubated for
5 min at 25C, for 30 min at 40C, and for 5 min at 85C.
Primers and probes for quantitative analyses
Primers and probes were designed using the Primer3 program
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) and
the Primer Express 2.0 software (Applied Biosystems, California,
USA), which generates oligonucleotides with similar melting
temperatures and minimal self complementarity. To avoid ampli-
ﬁcation of genomic DNA, the probes were placed at the junction of
two exons. Gene speciﬁcity of the primers and probes and the
absence of DNA polymorphism were conﬁrmed by BLAST searches.
Primers and probes were synthesised by Eurogentec (Seraing,
Belgium). Primer concentrations were tested for each primer at
concentrations of 50 nM, 300 nM, and 900 nM, choosing the
combination that displayed the lowest Ct value. Primer sequences
are shown in Table I. For IL-1b the predeveloped Taq Man assay
(Applied Biosystems, California, USA) was used.
Real-time PCR ampliﬁcation and analysis
Real-time PCR ampliﬁcation was performed and monitored
using an ABI Prism 7500 Fast Real-time PCR System (Applied
Biosystems, California, USA). The master mix was based on the
Table II
Descriptive statistics
Scaffold n Age at biopsy Male/female Processing time (days) Biopsies
MACI 22 33.64 7.33 18/4 66.55 21.77 3
HyalograftC 91 33.91 8.91 61/30 74.78 31.25 18
CaReS 26 29.27 8.42 16/10 14.69 1.49 5
Novocart3D 26 29.81 8.07 20/6 27.96 5.84 0
Total 165 32.46 8.67 115/50 26
Table I
Description of the designed primers and probes
mRNA template Primer sequence
Col1a1 left:
right:
probe:
50-atgcctggtgaacgtggt-30
50-aggagagccatcagcacct-30
50-accagcatcacctctgtcaccctta-30
Col2a1 left:
right:
probe:
50-gcctggtgtcatgggttt-30
50-gtcccttctcaccagctttg-30
50-aaaggtgccaacggtgagcct-30
aggrecan left:
right:
probe:
50-tcgaggacagcgaggcc-30
50-tcgagggtgtagcgtgtagaga-30
50-atggaacacgatgcctttcaccacga-30
versican left:
right:
probe:
50-tggaatgatgttccctgcaa-30
50-aaggtcttggcattttctacaacag-30
50-ctggccgcaagcaactgttccttt-30
MIA left:
right:
probe:
50-gaggaccagaccctgaaacct-30
50-gctgagctcactggcagtagaa-30
50-tcccatttgtctgtcttcacatcgactttg-30
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conditions comprised the initial steps at 50C for 2 min and at 95C
for 10 min. Ampliﬁcation of the cDNA products was performedwith
40 PCR cycles, consisting of a denaturation step at 95C for 15 s and
an extension step at 60C for 1 min. Beta-2-microglobulin (B2M)
was chosen as the internal standard, using the predeveloped Taq
Man assay (Applied Biosystems, California, USA), since it showed
the most consistent expression in our experimental setup and it
was already suggested for a similar setup by Foldagar et al.36. For
a given amount of cDNA the range of the housekeeping gene was
withinþ/ 1.5 Ct of themedian value, samples outside of this range
were excluded from analysis. All cDNA samples (2.4 ml in 20 ml)
were analyzed in triplicate. The ﬁnal numeric value was calculated
as the ratio of the gene to B2M andwas expressed in arbitrary units.
Electron microscopy and histology
Scanning electron microscopic samples were ﬁxed in 2.5%
glutaraldehyde in 0.1 M sodium cacodylate buffer. After rinsing
with distilled water they were chemically dehydrated with 2,
2-Dimethoxypropane and dried with hexamethyldisilazane.
Samples were then sputter-coated with gold and analyzed in
a Philips XL 20 scanning electron microscope.
For histological examinations standard protocols were used. In
brief, the transplant samples were ﬁxed with 7.5% para-
formaldehyde, dehydrated in a series of alcohol, rinsed in xylol and
inﬁltrated with parafﬁn. Deparafﬁnized sections were stained with
haematoxylin and eosin, alcian blue and fast red or DAPI.
Statistical analysis
All samples were assayed by real-time PCR in triplicates.
Statistical evaluation was performed using SPSS software version
17.0 (SPSS Inc., Chicago, USA). Values of the transplant processing
time are presented as mean standard deviation (SD). Gene
expression values are presented as boxplot diagrams. Outliers and
extreme outliers were deﬁned as an observation 1.5 and 3.0  the
interquartile range outside the central box, respectively. Normal
distribution of the DDCt values was tested by the Kolmogor-
oveSmirnov test. Differences between groups were assessed by
one-way ANOVA and Scheffé post hoc test and were considered
statistically signiﬁcant when P values were lower than 0.05.
Results
Residuals of 165 cartilage transplants (MACI n¼ 22,
HyalograftC n¼ 91, CaReS n¼ 26 and Novocart3D n¼ 26) were
collected during surgery and analyzed by real-time PCR. Thesenumbers refer to all data presentations and statistical calculations,
except for IL-1b, where they are separately speciﬁed. The distri-
bution of patients’ age and sex is shown in Table II.
From 26 patients residuals of the initial biopsy were collected
during arthroscopy. These biopsy samples served as control group
for native cartilage, in order to analyze the changes occurring
during the cultivation process of the different scaffolds.
From the date of biopsy and date of implantation the processing
time of each scaffold was calculated. This processing time included
the transport, the isolation and the cultivation of the cells until the
designated implantation date. The mean values of the processing
time were 67 22 days for MACI, 75 31 days for HyalograftC,
151 days for CaReS and 28 6 days for Novocart 3D (Table II).
Scaffold morphology
Scanning electron and light microscopy revealed very different
architecture of the four scaffold types (S.E.M. pictures showing
scaffolds without cells in Fig. 1). MACI consist of a dense, ﬁbrous
network of small and large ﬁbres with unilateral orientation
[Fig. 1(A, C, D)], while HyalograftC forms a non woven web of
regular ﬁbres with large inter-ﬁbre distances [Fig. 1(E, G, H)]. The
collagen gel CaReS consists of irregular ﬁbres and ﬁne ﬁbrillar
material in the interﬁber space [Fig. 1(I, K, L)]. Novocart3D has the
most complex architecture with more or less parallel plates inter-
connected with small ﬁbres [Fig. 1(M, O, P)].
The chondrocytes are unilaterally distributed on the surface of
MACI [Fig. 1(B)] and form a subconﬂuent to multi-cell layer of
mainly elongated cells [Fig.1(C, D)]. In the three other scaffold types
the cells are three-dimensionally distributed [Fig. 1(F, J, N)] but vary
in cell number and cell morphology. While HyalograftC [Fig. 1(G,
H)] and CaReS [Fig. 1(K, L)] contain a sparse quantity of cells which
are either spherical or elongated, most cells with mainly spherical
morphology were found in Novocart3D [Fig. 1(O, P)].
Gene expression analysis
In the biopsies Col1 expression showed a very high variance and
no signiﬁcant differences to the transplant samples, with the
exception of Novocart3D, which expressed Col1 lowest (5.3-fold
decrease compared to native cartilage, P< 0.001). The highest
Col1 expression of all scaffolds was found in MACI, the lowest in
Novocart3D (14.3-fold decrease compared to MACI, P¼ 0.001).
No signiﬁcant differences were seen between HyalograftC and
CaReS [Fig. 2(A)].
A dramatically lower Col2 expression in cells cultured in CaReS
vs native cartilage was found [832-fold lower, P< 0.001, Fig. 2(B)].
Although the variance in Col2 expression was very high, especially
in HyalograftC, the mean values of the different scaffolds were
very similar, with the exception of CaReS, which showed a signif-
icant higher Col2 expression than the others (18-fold, P< 0.001
compared to HyalograftC and Novocart3D).
Very similar results were found for aggrecan [Fig. 2(D)], whose
expression decreased during the cultivation (5-fold decrease,
P¼ 0.001, CaReS compared to native cartilage). Like Col2, aggrecan
was expressed signiﬁcantly more in CaReS than in the other
Fig. 1. S.E.M., DAPI and histological images of the four different scaffold types: MACI (AeD), HyalograftC (EeH), CaReS (IeL) and Novocart3D (MeP). S.E.M. showing the scaffold
structure of the four transplant types without cells (A, E, I, M). Scale bar: 100 mm. DAPI stainings illustrate the different cell distribution in the four transplant types (B, F, J, N). Scale
bar: 500 mm. Cell morphology is shown in histological alcian blue stainings (C, D, K, L, O, P) or HE stainings (G, H). Scale bar: 100 mm. In MACI the cells form a subconﬂuent to
multi-cell layer of mainly elongated cells (D, arrow). While HyalograftC and CaReS contain either elongated (H, L, arrow) or spherical (H, L, small arrow) chondrocytes, cells with
mainly spherical morphology (P, small arrows) were found in Novocart3D.
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vs aggrecan expression revealed a high correlation between these
two genes in all transplant and biopsy samples [Fig. 4(A)].
The large ﬁbroblast proteoglycan versicanwas expressed lowest
in Novocart3D [Fig. 2(C)], followed by MACI (1.6-fold, P¼ 0.495,
compared to Novocart3D) and the other two scaffolds (both
3-fold, P< 0.001, compared to Novocart3D). No signiﬁcant differ-
ence between the biopsies and the transplant samples, except for
Novocart3D (2.5-fold decrease, P¼ 0.005, compared to native
cartilage), were observed for versican.
MIA or cartilage-derived retinoic acid sensitive protein
(CD-RAP) is a protein expressed in developing andmature cartilage.
Since its expression is required for cartilage differentiation and
depends directly on the differentiation status of the cells37,38, we
have chosen MIA as a further differentiation marker for chon-
drocytes. A good correlation between MIA and the chondrogenicphenotype marker Col2 was demonstrated, when plotting Col2 vs
MIA expression of all transplant and biopsy samples [Fig. 4(B)]. MIA
expression was found to be signiﬁcantly reduced in the transplant
samples compared to native cartilage (5.9-fold decrease, P¼ 0.005,
CaReS compared to native cartilage) [Fig. 3(A)]. Among the
transplants CaReS and HyalograftC exhibited a signiﬁcantly
higher expression of MIA than MACI and Novocart3D (>7-fold,
P< 0.001).
Due to the very low expression level of IL-1b in non-osteoarthritic
chondrocytes, IL-1bwas detected only in six biopsy samples showing
no signiﬁcant differences between the biopsy and the transplants
[Fig. 3(B)]. Out of 25 CaReS samples only ﬁvewere positive for IL-1b
suggesting a very low expression in this type of scaffold. However, no
statistical signiﬁcance was observed owing to the low number of
positive sample. Novocart3D (n¼ 24) showed also low levels of IL-
1b compared to MACI (n¼ 16, 33.3-fold decrease, P< 0.001) and
Fig. 2. Real-time PCR analysis of Col1 (A), Col2 (B), aggrecan (C) and versican (D) expression in four different transplant types [MACI (n¼ 22), HyalograftC (n¼ 91), CaReS
(n¼ 26) and Novocart3D (n¼ 26)] and in cartilage biopsies (n¼ 26). Gene expression was normalized to B2M. The gene expression values were plotted in a boxplot diagram (black
line¼median; top of grey box¼ 25. percentile, bottom of grey box¼ 75. percentile, whisker¼ 1.5-fold box height or minimum and maximum value respectively, dot¼ outlier,
asterisk¼ extreme outlier).
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MIA expression, varied highest in HyalograftC.
In accordance with Col2 and aggrecan expression, the two
calculated ratios (Col2/Col1 and aggrecan/versican) fell
dramatically in the transplant samples compared to native cartilage
(762-fold decrease, P< 0.001 and 6-fold decrease, P< 0.001,
respectively, CaReS compared to native cartilage) [Fig. 3(C, D)]. As
regards the Col2/Col1 ratio, CaReS comprised the most differen-
tiated chondrocytes among the transplants (15-fold higher than
Novocart3D, P< 0.001). No signiﬁcant differences were observed
between the other scaffolds. CaReS also exhibited the highest
aggrecan/versican ratio, followed by MACI (5.9-fold decrease,
P< 0.001, compared to CaReS), Novocart 3D (9.1-fold decrease,
P< 0.001) and HyalograftC showing the lowest aggrecan/versican
ratio (25-fold decrease, P< 0.001).
Discussion
Scaffold composition and architecture is believed to have
considerable impact on the differentiation and morphology of the
seeded cells. In this study we have therefore analyzed the inﬂuence
of scaffold composition and structure on the expression of
cartilage-speciﬁc genes in four different clinical applied graft
systems. Beside the differences between the transplant types, we
also evaluated their gene expression levels at the time point of
transplantation in relation to native cartilage.
Comparison of native cartilage with transplants
In general, 3D conditions are believed to stimulate or preserve
the differentiated stage of chondrocytes. However, despite thecultivation on three dimensional scaffolds Col2, aggrecan and MIA
dramatically decreased, either as a relic of monolayer cultivation or
due to inefﬁcient differentiation on and in the scaffold. Interest-
ingly, almost no change in Col1 expression was found, although
several studies have demonstrated an increase in Col1 expression
already a short time after cell isolation39,40. In articular cartilage
Col1 is expressed especially in the superﬁcial layer41. With the
exception of Novocart3D, cartilage is collected by scratching with
a sharp spoon, resulting in a disproportionately high proportion of
the superﬁcial layer and with it cells expressing Col1. In addition,
the biopsies are taken from the notch, a non-weight-bearing area,
in which the Col1 expression might be higher than in
weight-bearing areas. For Novocart3D the biopsies are taken from
the notch in form of cylinders and it is not speciﬁed which cells are
used by the company.Scaffold comparison
Of all analyzed scaffolds CaReS exhibited the highest Col2,
aggrecan and MIA expression, indicating a relatively high differ-
entiation of cells compared to the other transplants. In contrast to
the other scaffolds the cells are seeded in the collagen gel imme-
diately after cell isolation, skipping the propagation step in
monolayer culture, which leads to dedifferentiation. In addition,
the shortest total cultivation time of all graft systems is used for the
collagen gel giving the cells only a short time to propagate and
dedifferentiate. Nevertheless, distinct signs of an ongoing dedif-
ferentiation process can be observed. Beside the highly diminished
Col2 and aggrecan expression compared to native cartilage, many
cells appear elongated in histology. This cell shape may be sup-
ported by the speciﬁc scaffold characteristics. As suggested by
Fig. 3. Real-time PCR analysis of MIA (A) and IL-1b (B) expression in four different transplant types [MACI (n¼ 22), HyalograftC (n¼ 91), CaReS (n¼ 26) and Novocart3D
(n¼ 26)] and in cartilage biopsies (n¼ 26). Due to the overall low IL-1b expression only IL-1b positive samples were included into the analysis [MACI (n¼ 16), HyalograftC
(n¼ 69), CaReS (n¼ 5), Novocart3D (n¼ 24), cartilage biopsies (n¼ 6)]. The Col2/Col1 (C) and aggrecan/versican (D) ratios were calculated by division of Col1 and
versican expression by Col2 and aggrecan expression, respectively. Gene expression was normalized to B2M. The gene expression values were plotted in a boxplot diagram (black
line¼median; top of grey box¼ 25. percentile, bottom of grey box¼ 75. percentile, whisker¼ 1.5-fold box height or minimum and maximum value respectively, dot¼ outlier,
asterisk¼ extreme outlier).
C. Albrecht et al. / Osteoarthritis and Cartilage 19 (2011) 1219e12271224Nürnberger et al., the dense network of small collagen ﬁbres
supports a ﬂattened cell shape and the formation of cell
extensions42.
HyalograftC had the highest variance in matrix gene expres-
sion. This may result from the longest andmost variable cultivation
time of all analyzed scaffolds, which implicates that the cells
undergo variable cell doublings and passages to reach the right cell
number needed for seeding at the target density. Different inter-
actions of the cells with the scaffold’s hyaluronan ﬁbres could alsoFig. 4. Correlation between Col2 and aggrecan expression (A) and Col2 and MIA expression (
y-axis vs the relative aggrecan (A) or MIA (B) expression of all transplant and biopsy sampcontribute to the high variance in gene expression, since
a concentration dependent inﬂuence of hyaluronan on chondrocyte
proliferation and proteoglycan production has been demonstrated
in several studies43,44. Another property of the scaffold is its open
organisation with large space between the hyaluronan ﬁbres.
Therefore the cellular behaviour is only lightly guided by the scaf-
fold, resulting in a high dependence on interindividual differences
of the cells. Binding of the cells to hyaluronan is achieved by the
CD44 receptor. A recent paper of our working group demonstratedB). The relative Col2 expression of all transplant and biopsy samples were plotted on the
les on the x-axis.
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indicating a high binding capacity of the dedifferentiated cells to
the hyaluronan ﬁbres. This would explain why the cells are very
equally distributed, despite the open organisation of the scaffold
and subsequent difﬁculties for cell seeding.
In Novocart3D, the low expression of all matrix components
may be due to the short cultivation time of the cells on the scaffold
before shipping. In contrast to the other grafts, the cells are seeded
on the scaffold only 2 days before shipping, so the cells have only
little time to adapt to the new culture conditions, which might
make the cells more vulnerable to the transport. This stress may
lead to the lowest gene expression, except for MIA, in all analyzed
scaffolds. We can therefore speculate that the cells are only
temporarily metabolically inactive. However, regarding the Col2/
Col1 ratio the cells exhibit the second highest differentiation, which
correlates with the morphology of the chondrocytes: most of them
appear spherical and only some exhibit a polygonal cell shape.
In MACI, the cells showed a comparable high Col1 expression
in the transplants. This particularity can be explained by the
behaviour of the cells on that scaffold, which do somewhat invade
the scaffold material, but tend to form cell-multilayer on the scaf-
fold surface. The cells in the multilayer are elongated and
ﬁbroblast-like and are probably responsible for the high production
of Col1 compared to the other scaffolds. On the other hand, several
studies have demonstrated that high density cultures can retain the
differentiation of chondrocytes46,47. Therefore we can speculate
that the high cell density causes the relatively high production of
aggrecan in comparison to HyalograftC and Novocart3D, which is
probably a sign of ongoing differentiation.
In general, IL-1, a proinﬂammatory cytokine, is expressed in
osteoarthritic cartilage and is known to induce cartilage degrada-
tion. Since this factor may also negatively affect the transplant, IL-1
expression was analyzed in the transplant samples. Monolayer
culture of human chondrocytes was shown to increase IL-1
expression48. We couldn’t ﬁnd any signiﬁcant differences in IL-1b
expression between the biopsies and cartilage transplants indi-
cating that the expression levels are restored by 3D culture
conditions. This observation, however, may also result from the low
number of cartilage biopsies, fromwhich only six were positive for
IL-1b. Between the scaffolds there were obvious differences in IL-1
expression, showing low levels of IL-1b in CaReS and Novocart3D
and higher levels in Chondrogide and HyalograftC. The higher
expression in the two latter grafts could be caused by the long
cultivation of cells in monolayer culture implicating a higher
passage number. In addition to the high expression of IL-1b in
HyalograftC, a huge variance in expression was noticeable
between the individual samples. This variance may result from
interactions with hyaluronan, as this glycosaminoglycan was
demonstrated to modulate inﬂammation and IL-1b expression
dependent on its molecular weight49,50. Since IL-1b expressionwas
generally very low in all samples and in order to avoid false positive
samples, only samples that were positive for IL1-b were included
into these analyses. Speciﬁcally, IL-1b couldn’t be detected in many
of CaReS and biopsy samples. An even lower level of expression
can therefore be assumed for those groups.
To our knowledge this is the ﬁrst study comparing more than
two different, clinically used transplant types on the molecular
level. In contrast to histological and morphological scores, gene
expression results by real-time PCR have the advantage of being
person-independent. However, gene expression analysis repre-
sents the whole sample e not differing between sample regions or
single cells. In addition, the number of cells is not taken into
account, but could inﬂuence the results. A large difference in cell
count can be assumed between the scaffolds, due to the highly
different culture durations and conditions by the companies. Dataabout the inﬂuence of cell number or cell differentiation on the
outcome of chondrocyte transplantation are still missing. As
a result we do not know if it is more important to accept low cell
numbers for high differentiated cells, or if a high cell number of
more dedifferentiated cells is required to rebuild the ECM of the
cartilage defect. For this reason our results are mostly descriptive
and we cannot predict the clinical outcome on the basis of our
results. Large prospective clinical studies comparing different grafts
would be needed to reveal the inﬂuence of the analyzed factors on
the clinical outcome after transplantation. Once clinically relevant
values are deﬁned, real-time PCR could serve as an easy way for
controlling transplant criteria before implantation.
Conclusion
Our data demonstrates that the gene expression and cell
differentiation differ highly between the analyzed scaffolds at the
time point of transplantation. These differences seem to result from
scaffold characteristics as well as from culture conditions, e.g.,
highly variable passage numbers, by the companies. Despite the
cultivation under 3D conditions, the cell differentiation on all
transplant types didn’t reach the levels of native cartilage. Further
clinical trials comparing the different transplant types are needed
to clarify the inﬂuence of the analyzed parameters on the clinical
outcome.
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